SCHEMBL17653189

SCHEMBL17653189

CC(C)CCN(C(=O)O)c1nc(NCCO)c2cc(-c3ccncc3)ccc2n1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AAK1 Q2M2I8 7/20 0.44
LRRK2 Q5S007 2/20 0.40
GSK3B P49841 2/20 0.40
JAK2 O60674 1/20 0.40
ROCK2 O75116 1/20 0.40
MAP4K4 O95819 1/20 0.40
RPS6KB1 P23443 1/20 0.40
TYK2 P29597 1/20 0.40
CLK2 P49760 1/20 0.40
ROCK1 Q13464 1/20 0.40
DYRK1A Q13627 1/20 0.40
CLK4 Q9HAZ1 1/20 0.40
PRKCH P24723 1/20 0.40
PRKCE Q02156 1/20 0.40
PRKCQ Q04759 1/20 0.40
PRKCD Q05655 1/20 0.40
LATS1 O95835 1/20 0.40
LATS2 Q9NRM7 1/20 0.40
TRIM58 Q8NG06 2/20 0.38
KCNH2 Q12809 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17653264 0.90 AAK1 (0.40) AAK1LRRK2GSK3BJAK2ROCK2
SCHEMBL17653179 0.82 AAK1 (0.62) AAK1LRRK2GSK3BJAK2ROCK2
SCHEMBL17653203 0.80 AAK1 (0.47) AAK1LRRK2GSK3BCHEK1MKNK1
SCHEMBL17653250 0.79 AAK1 (0.55) AAK1LRRK2GSK3BKCNH2ATM
SCHEMBL17653111 0.75 AAK1 (0.59) AAK1LRRK2GSK3BKCNH2ATM
SCHEMBL19253018 0.75 AAK1 (0.45) AAK1LRRK2GSK3BJAK2ROCK2
SCHEMBL17653311 0.74 AAK1 (0.60) AAK1ROCK2MAP4K4TRIM58ALDH1A1
SCHEMBL17653269 0.71 AAK1 (0.42) AAK1GSK3BCHEK1MKNK1BMP2K
SCHEMBL17663501 0.70 AAK1 (0.59) AAK1LRRK2GSK3BJAK2ROCK2
SCHEMBL4360601 0.70 MAP4K4 (0.56) MAP4K4CLK4CD38ALDH1A1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3200797-A1 QUINAZOLINE-BASED KINASE INHIBITORS Bristol-Myers Squibb Company (US) 2017-08-09 EP disclosed
WO-2016053794-A1 QUINAZOLINE-BASED KINASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2016-04-07 WO disclosed